On July 28, 2016, the State Council issued the 13th five year national science and technology innovation plan. It is mentioned in Article 3 "development of population health technology" and section 5 "in vitro diagnosis products" of Chapter 6 "improving the technical system supporting the improvement of people's livelihood and sustainable development". It is mentioned that it is necessary to "develop automatic nucleic acid detection system, high-throughput liquid suspension chip, medical biomass spectrometer, rapid pathological diagnosis system and other major products, and develop a batch of early diagnosis and accurate diagnosis of major diseases, therapeutic diagnostic reagents and high-precision diagnostic products suitable for primary medical institutions will enhance the competitiveness of China's IVD industry.